Establishing secure connection…Loading editor…Preparing document…

Healthcare Clinical Trial Addendum

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL TRIAL ADDENDUM

Patient Information

Patient Name:    Date of Birth:

Insurance and Billing

Policy Number:    Group Number:

Clinical Trial Identification

Study Title:

Protocol Number:    Sponsor:

Principal Investigator:    Site:

Enrollment Date (if enrolled):    Study Phase: Phase I Phase II Phase III

Addendum Purpose and Scope

This Clinical Trial Addendum supplements and modifies the previously executed informed consent for clinical care or research. All terms of the existing consent remain in force except as expressly modified below. By signing this addendum, the patient acknowledges receipt of trial-specific information and consents to the additional procedures and disclosures described herein.

Trial Procedures, Duration and Additional Visits

Risks, Benefits and Alternatives

The patient acknowledges that participation in the trial may involve risks not associated with routine care and that potential benefits specific to the investigational intervention have been explained. The patient retains the right to withdraw from the trial at any time without penalty to their standard medical care.

Costs, Compensation and Injury

Will the patient incur additional costs as a result of trial procedures?    Yes    No

Will the patient receive compensation for participation?    Yes    No

In the event of trial-related injury, medical care will be provided as described in the informed consent and as required by applicable regulations. Information about compensation or treatment for research-related injury has been provided.

Confidentiality, Data Use and Record Release

The patient authorizes release of relevant medical records and trial data to the sponsor, monitor, ethics committee, and regulatory authorities for the purposes of monitoring, audit, and regulatory compliance. Such disclosures may include identifiable health information as necessary. De-identified data may also be used for future research and publication.

I authorize release of my medical information as required for the conduct of this study:    I authorize

HIPAA Authorization for Research Use

By signing this addendum I authorize use and disclosure of my protected health information (PHI) for the purposes of the clinical trial, including collection, analysis, and long-term storage. I understand that my authorization is voluntary and that I may revoke it in writing except to the extent that action has already been taken in reliance on this authorization.

Withdrawal and Questions

Participation in the trial is voluntary. I may withdraw consent for trial procedures at any time without prejudice to my ongoing medical care. Withdrawal procedures and consequences have been explained to me, including how my data collected prior to withdrawal will be handled.

Prior Consent Reference

This addendum references the original informed consent signed on: . Protocol documents and the informed consent form provided earlier continue to govern except as modified herein.

Acknowledgment and Consent

By signing below, I acknowledge that I have read and understand this Clinical Trial Addendum, that my questions have been answered, and that I consent to the additional procedures, uses, and disclosures described above. I understand I may revoke this authorization in writing to the study contact, except to the extent that the study has already acted in reliance on this authorization.

Patient Name:

Signature:

Date:

Enter text✕

What the Healthcare Clinical Trial Addendum Is

The Healthcare Clinical Trial Addendum is a contract amendment used to supplement a master clinical trial agreement with provisions specific to a study or site. It clarifies responsibilities for data handling, patient privacy, safety reporting, intellectual property rights, indemnification, and subcontracting by CROs or vendors. Typical addenda address HIPAA-compliant data use, study-specific consent language, source data access, monitoring logistics, and procedures for protocol deviations. Parties use the addendum to align regulatory obligations, specify timelines for adverse event reporting, and document any deviations from the parent agreement before enrolling participants.

Why a Focused Addendum Matters

A Healthcare Clinical Trial Addendum reduces ambiguity by allocating regulatory responsibilities, specifying data privacy and HIPAA safeguards, and defining reporting and monitoring duties. Clear addenda lower legal risk, speed institutional approvals, and help ensure participant protections are consistently applied across sponsor, CRO, and site relationships.

Why a Focused Addendum Matters

Who Typically Prepares and Signs This Addendum

Sponsors, clinical research organizations, investigative sites, and institutional legal or compliance departments typically prepare and execute these addenda.

  • Sponsors and in-house legal teams: define obligations, funding, data access, and indemnity terms.
  • CROs and vendors: document operational responsibilities, monitoring, subcontracting, and data transfer processes.
  • Investigative sites and principal investigators: confirm IRB coordination, consent language, and source data access.

Institutional review boards, data privacy officers, and external counsel commonly review final language prior to signature and site activation.

Core Clauses You Should Expect in the Addendum

Core clauses commonly included in a Healthcare Clinical Trial Addendum clarify scope, data handling, reporting, IP, liability, and amendment procedures tailored to study specifics.

Scope of Work

Describe the study-specific activities, enrollment targets, responsibilities of sponsor, CRO, and site, including ancillary services, timelines, deliverables, and any deviations from the master clinical trial agreement.

Data Privacy

Specify protected health information handling, permitted uses and disclosures, de-identification methods, security controls, and any Business Associate Agreement requirements to satisfy HIPAA and institutional policies.

Safety Reporting

Define adverse event reporting timelines, responsible parties for expedited reports, serious adverse event escalation procedures, and requirements for notification to IRBs and regulatory agencies.

Intellectual Property

Allocate ownership and publication rights for trial data and inventions, describe prepublication review periods, redaction for confidential information, and post-trial data sharing conditions.

Liability & Indemnity

Set indemnification scope, insurance minimums, limitation of liability clauses, allocation of negligence, and responsibilities for third-party claims arising from trial conduct.

Amendments & Term

State procedures for amending the addendum, required approvals, effective dates for changes, and termination rights tied to regulatory actions or enrollment failures.

Stepwise Process to Prepare and Execute the Addendum

Follow these sequential steps to complete, approve, and circulate a Healthcare Clinical Trial Addendum without unnecessary delay.

  • 01
    Prepare Draft: Attach master agreement and identify study-specific changes.
  • 02
    Legal Review: Have counsel review privacy, indemnity, and IP clauses.
  • 03
    IRB Coordination: Confirm consent language and obtain IRB concurrence.
  • 04
    Execute & Distribute: Collect signatures, date the addendum, and circulate final copies.

How to Configure an Online Workflow for the Addendum

Configure an online workflow to collect signatures, enforce authentication, and automate distribution for the addendum.

Field Configuration
Template Name Master addendum template with variables
Authentication Email + SMS code or SSO where required
Routing Order Sponsor → CRO → Site sequential signing
Retention Policy Auto-archive for retention period with audit trail

Where to File, Send, or Submit an Executed Addendum

This section outlines where to file or send an executed Healthcare Clinical Trial Addendum and how records are routed.

  • Sponsor Legal: Store executed copy in sponsor contract repository.
  • CRO Records: Upload to CRO document management system with audit trail.
  • IRB: Provide final addendum to IRB for their file.
  • Site Files: Keep signed addendum in site's regulatory binder.

Digital Signing and Platform Requirements

Use an eSignature platform that supports HIPAA, audit trails, and common file formats (PDF, DOCX) for secure execution.

  • File Formats: PDF and DOCX supported
  • Integrations: Salesforce, NetSuite, Google Workspace integrations
  • Authentication: Email, SMS, SSO options

Key Timelines and Deadlines to Track

Key timeframes for approvals, reporting, and execution of the Healthcare Clinical Trial Addendum are summarized below.

IRB approval before enrollment:

IRB must approve consent and addendum before participant enrollment.

SAE reporting deadlines:

Report serious adverse events per FDA timelines, typically within 24–48 hours.

Effective date upon execution:

Addendum takes effect on the date signed by all parties.

Protocol deviation notification:

Notify sponsor and IRB promptly as required by agreement.

Retention and access timelines:

Maintain records per HIPAA and sponsor retention policies.

Milestones from Draft to First Patient Visit

A sequential view of key milestones shows negotiation through first patient visit for the addendum lifecycle.

01

Negotiation & Drafting

Parties exchange proposed language and resolve issues.

02

Legal and IRB Review

Counsel and IRB verify compliance and consent alignment.

03

Execution & Signature

Authorized representatives sign and date the addendum.

04

Implementation & Recordkeeping

Distribute executed copies and update trial documentation.

Common Preparation Mistakes to Avoid

  • Using ambiguous data-sharing language that fails to specify de-identification standards or permitted secondary uses, creating compliance gaps under HIPAA and sponsor policies.
  • Neglecting to align addendum effective date with IRB approval and signed informed consent versions, which can invalidate participant enrollment documentation.
  • Omitting explicit audit or monitoring access rights for sponsors and CROs, leading to disputes during inspections or monitoring visits.
  • Failing to require a Business Associate Agreement when PHI is shared with vendors, exposing parties to regulatory and contractual liability.

Potential Penalties and Contractual Risks

Regulatory Fines: Civil penalties under HIPAA
Contractual Liability: Breach damages and indemnity obligations
Data Breach Costs: Notification, remediation, and legal fees
Enrollment Delays: Study start and milestone impacts
Invalid Consent: Risk of unusable data
Audit Exposure: Regulatory inspection and penalties

Required Information and Common Data Elements

Patient Identifiers: Name, DOB, MRN, and contact details
Protocol Number: Sponsor protocol identifier exactly as filed
PI Contact: Principal investigator name and address
Signatures: Typed name, signature, and date
Consent Version: IRB-approved consent version date
Data Access List: Authorized users and access rights

Real-World Use Cases

Real-world scenarios show how addenda resolve site-specific needs, streamline approvals, and document privacy obligations before trial enrollment.

Academic Medical Center

An academic medical center used an addendum to standardize vendor data access across multiple departments and harmonize IRB-required consent language for a multicenter oncology study.

  • Resulted in fewer review cycles and consistent consent text.
  • Uniform addendum language reduced negotiation time, lowered the number of IRB queries, and ensured audit trails for data sharing requests, which simplified monitoring visits and reduced administrative burden on research coordinators across participating sites.

Community Research Site

A community research site added specific payment schedules and monitoring windows to the addendum to align sponsor reimbursements with local staffing constraints.

  • Clarified invoicing and reduced late payments.
  • Clear clauses for billing cycles and visit windows prevented disputes, expedited reconciliations, and provided traceable records during audits, improving relationships with the sponsor and enabling timely participant follow-up and payments.

eSignature Vendor Pricing and Feature Comparison

Comparison of baseline eSignature vendor pricing and core features relevant to Healthcare Clinical Trial Addendum execution is shown below.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Trial available Trial available Trial available Trial available
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

Frequently Asked Questions and Common Concerns

Frequently asked questions about legal enforceability, e-signature use, HIPAA implications, and practical signing issues for the Healthcare Clinical Trial Addendum.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users